Abstract:A Disintegrin And Metalloproteinase 12 (ADAM12) is highly expressed in multiple cancers such as breast and cervical cancers and its high expression reduces the overall patient survival rate. ADAM12 has two major splicing variants, the long membrane-anchored form ADAM12L and the short secreted form ADAM12S. However, how they are regulated and whether they are modulated similarly or differently in cells are not clear. Here, we use affinity purification and mass spectrometry to identify the ADAM12S-interacting proteins. Spectral counting and MaxQuant label-free quantification reveal that ADAM12S but not ADAM12L specifically interacts with a subset of endoplasmic reticulum proteins, such as endoplasmin (GRP94), 78 kDa glucose-regulated protein (GRP78), and UDP-glucose:glycoprotein glucosyltransferase I (UGGT1), that regulate the folding and processing of secreted proteins. Further biochemical experiments validate the interaction between ADAM12S and several of its interacting proteins. Computational docking analysis demonstrates that GRP94 preferentially interacts with ADAM12S over ADAM12L. The data also suggest that both the protein expression level and the secretion of ADAM12S are regulated by GRP94 expression and knockdown. Our results reveal a link between these two proteins that are highly expressed in cancer cells. Furthermore, our studies define a new ADAM12S-specific regulator that may contribute to the cancer development. Significance: A Disintegrin And Metalloproteinase 12 (ADAM12) is highly expressed in many cancers such as lung, breast, and cervical cancers. ADAM12 has two major splicing variants, the long membrane-anchored form ADAM12L and the short secreted form ADAM12S. However, how they are regulated and whether they are modulated similarly or differently are not completely understood. We use affinity purification and label-free quantitative proteomics to identify the ADAM12S-interacting proteins. Our results reveal that ADAM12S specifically interacts with a subset of endoplasmic reticulum proteins, including endoplasmin (GRP94), UDP-glucose:glycoprotein glucosyltransferase I (UGGT1), and neutral α-glucosidase AB (GANAB). Computer modeling reveals that ADAM12S interacts with the surface amino acids of GRP94 more strongly than ADAM12L. Biochemical experiments further reveal that GRP94 regulates both the protein level and the secretion of ADAM12S. Database mining finds that both GRP94 and ADAM12 are highly expressed in multiple cancers and their high expression is correlated with poor patient survival rate. Taken together, our work discovers a new upstream regulator for ADAM12S, which may contribute to its distinct functions in the regulation of the migration and invasion of cancer cells.

Proteomics and Biochemical Analyses of Secreted Proteins Revealed a Novel Mechanism by Which ADAM12S Regulates the Migration of Gastric Cancer Cells

ADAM17 Promotes Epithelial-Mesenchymal Transition Via TGF-β/Smad Pathway in Gastric Carcinoma Cells

Quantitative proteomics and biochemical analyses reveal the role of endoplasmin in the regulation of the expression and secretion of A Disintegrin And Metalloproteinase 12

ADAMTS12 Mediates Vascular Abnormality to Enhance Chemoresistance Via the MAPK/VEGF Signaling Pathway in Gastric Cancer

ADAMTS12 Promotes Migration and Epithelial-Mesenchymal Transition and Predicts Poor Prognosis for Pancreatic Cancer.

promotes migration and epithelial-mesenchymal transition and predicts poor prognosis for pancreatic cancer

A New Strategy to Identify ADAM12 and PDGFRB As a Novel Prognostic Biomarker for Matrine Regulates Gastric Cancer Via High Throughput Chip Mining and Computational Verification.

SILAC Quantitative Proteomics and Biochemical Analyses Reveal a Novel Molecular Mechanism by which ADAM12S Promotes the Proliferation, Migration, and Invasion of Small Cell Lung Cancer Cells through Upregulating Hexokinase 1.

ADMA mediates gastric cancer cell migration and invasion via Wnt/β-catenin signaling pathway

ADAMTS12 promotes oxaliplatin chemoresistance and angiogenesis in gastric cancer through VEGF upregulation

ADAM17 Promotes Lymph Node Metastasis in Gastric Cancer Via Activation of the Notch and Wnt Signaling Pathways

Molecular Mechanism of Pancreatic Tumor Metastasis Inhibition by Gd@C82(OH)22 and Its Implication for De Novo Design of Nanomedicine.

Quantitative Proteomics Identifies Myoferlin As a Novel Regulator of A Disintegrin and Metalloproteinase 12 in HeLa Cells.

Methylation Status of ADAM12 Promoter Are Associated with Its Expression Levels in Colorectal Cancer.

Polypeptide N-Acetylgalactosaminyltransferase 2 Regulates Cellular Metastasis-Associated Behavior In Gastric Cancer

ADAMTS10 inhibits aggressiveness via JAK/STAT/c-MYC pathway and reprograms macrophage to create an anti-malignant microenvironment in gastric cancer

Cxcl16 Promotes Gastric Cancer Tumorigenesis Via Adam10-Dependent Cxcl16/Cxcr6 Axis And Activates Akt And Mapk Signaling Pathways

ADAMTS19 Suppresses Cell Migration and Invasion by Targeting S100A16 via the NF-κB Pathway in Human Gastric Cancer

Integrated Proteome and Phosphoproteome Analysis of Gastric Adenocarcinoma Reveals Molecular Signatures Capable of Stratifying Patient Outcome.

Metadherin Regulates Actin Cytoskeletal Remodeling and Enhances Human Gastric Cancer Metastasis Via Epithelial-Mesenchymal Transition

ADAMTS12, a Novel Prognostic Predictor, Promotes Cell Proliferation, Migration and Invasion in Head and Neck Squamous Cell Carcinoma.